MICROMED CO., LTD.
Update：2023/06/12
Industries
Main Industry
Health Care
Main Product/Service
1. Concept Prototyping
2. Technology Actualization
3. Product Commercialization
4. Incubation
2. Technology Actualization
3. Product Commercialization
4. Incubation
Founded Year
2016
Unified Business No.
43800235
Status
Active
Number of Employees
11
Total Paid-in
Capital
34,035,657 (NT$)
Location of Company
Taiwan
, New Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
MicroMED is a MEMS design house specializing in the development of microinjection devices targeting unmet needs in the most challenging drug delivery applications. MicroMED has established a proprietary high-precision MEMS drug delivery engine system, capable of delivering broad flow rate from 1 nL/min to 10 mL/min with driving force upto 2,000 atm (29,000 psi) of pressure.
MicroMED welcomes all types of business connections/relations in the PDA drug delivery value chain (pharma, biotech, medical injector developer and insurance payer) with the goals below (but not limited to):
‧ Purchasing of the current micro-engine products ‧ Co-development of advanced injector products ‧ Licensing of the micro-engine proprietaries/intellectual properties.
MicroMED welcomes all types of business connections/relations in the PDA drug delivery value chain (pharma, biotech, medical injector developer and insurance payer) with the goals below (but not limited to):
‧ Purchasing of the current micro-engine products ‧ Co-development of advanced injector products ‧ Licensing of the micro-engine proprietaries/intellectual properties.
Corporate Video
